INTRODUCTION
============

Guidelines for intermittent haemodialysis dosing are based on urea kinetics \[[@sfy036-B1], [@sfy036-B2]\]. Different dialysis schedules can be compared using the continuous-equivalent urea clearances---standard urea clearance (stdK) and equivalent renal urea clearance (EKR), commonly scaled by the urea distribution volume (*V*): $$stdK/V = G/PAC/V$$$$EKR/V = G/TAC/V$$

The most convenient unit for stdK/*V* and EKR/*V* is per week. The dimensionless variable stdKt/*V* = weekly stdK/*V*. *G*, *V*, the predialysis concentration (PAC) and the time-averaged concentration (TAC) are derived from the double-pool urea kinetic model (UKM), which includes the renal urea clearance. EKR/*V* is always greater than stdK/*V*. Current European and American guidelines have no recommendations on the EKR.

Residual renal function (RRF) is qualitatively better than dialysis with equal urea clearance. The clinical significance of RRF can be expressed in different ways. In the new Solute Solver 'What if' module (version 1.17, 9 June 2017), Daugirdas has adopted a new method to calculate stdKt/*V*~urea~ in incremental haemodialysis \[[@sfy036-B3]\]. This method has been used also in the original Solute Solver since 15 December 2015 (e.g. version 2.08, 17 October 2017) \[[@sfy036-B4]\]. The fractional renal urea clearance *K*~rf~ is added to dialysis stdKt/*V*~d~, which results in a higher total stdKt/*V* than modelling with K~r~. The classic method has been used in earlier versions of the Solute Solver (e.g. version 1.97, 2 July 2010). The background of the new approach has been described by Daugirdas *et al*. \[[@sfy036-B5]\] and it has been incorporated into the Kidney Disease Outcomes Quality Initiative (KDOQI) 2015 guidelines \[[@sfy036-B2]\] with a target value of 2.3.

The new method has been used in the Frequent Hemodialysis Network (FHN) trials \[[@sfy036-B8], [@sfy036-B9]\] and also by Casino and Basile \[[@sfy036-B10]\], who have suggested adjusting the target as an alternative to modifying the measuring method. They propose that an EKR~c35~ of 12 mL/min/35 L (EKR/*V*=3.46/week) is an adequate continuous-equivalent dialysis urea clearance in anuric patients and that no dialysis is needed with a K~r~ of 6 mL/min/35 L (K~rf~ 1.73/week).

Casino and Basile \[[@sfy036-B10]\] obviously mean that total EKR/*V* should be equal to the adjusted target \[[Equations (4)](#E4){ref-type="disp-formula"} and [(8)](#E8){ref-type="disp-formula"}; for an explanation of the variables, see Abbreviations and variables in Appendix\]. So K~r~ is weighted by a factor of 2 compared with dialysis: $$\text{Adjusted~target~=~target~}EKR_{c35}–K_{rc35}$$$$\text{EKR}_{\text{dc}35} + K_{\text{rc}35} = \text{~adjusted~target}$$$$\text{EKR}_{\text{dc}35} = \text{~adjusted~target~EKR}_{c35}–\ 2*K_{\text{rc}35}$$$$\text{Adjusted~target~} = \text{~EKR}_{\text{dc}35} + \ 2*K_{\text{rc}35}$$

In EKR/*V* units, $$\text{Adjusted~target~} = \text{target\ EKR}/V–K_{\text{rf}}$$$$\text{EKR}/V_{d} + K_{\text{rf}} = \text{~adjusted~target}$$$$\text{EKR}/V_{d} = \text{~adjusted~target~}–\ 2*K_{\text{rf}}$$$$\text{Adjusted~target~} = \text{~EKR}/V_{d} + 2*K_{\text{rf}}$$

The aim of this study is to compare, by computer simulations, different methods of assessing the contribution of renal urea clearance to total continuous-equivalent urea clearance.

MATERIALS AND METHODS
=====================

Patients
--------

A study based on the same group of 33 patients with 205 dialysis sessions was published previously \[[@sfy036-B11]\]. Five of the sessions, in which all targets could not be achieved (due to a Q~b~ lower limit of 50 mL/min), were excluded from this study.

Computations
------------

If t~d~, K~d~, K~r~, UF, V, G and the schedule or frequency are known, the resulting average PAC, dialysis time TAC~d~, interval time TAC~i~, whole-cycle TAC~c~, EKR/*V* and stdK/*V* can be computed. Dialyser *in vivo* K~0~A can be calculated from Q~b~, Q~d~ and the online ionic dialysance using the Michaels equation.

[Tables 1](#sfy036-T1){ref-type="table"} and [2](#sfy036-T2){ref-type="table"} present the treatment data of a fictitious patient. The numbers in the 'Classic' and 'Without RRF' columns were computed with a program adapted from the Solute Solver 'What if' module using the same Runge--Kutta procedure \[4\], but with a symmetric schedule and the classic stdK/*V* calculation method including K~d~ and K~r~. Table 1.An example of ECC calculationClassicDaugirdasWithout RRFInput parameters Treatment frequency or schedule, per week3.03.01**3**5[^a^](#tblfn1){ref-type="table-fn"}1**3**5[^a^](#tblfn1){ref-type="table-fn"}3.03.03.0 Treatment time, min240240240240**612451340** Dialyser clearance, mL/min200200200200200200200 Renal clearance, mL/min0.0**4.0**0.0**4.0**0.00.00.0 Renal fractional clearance, per week0.001.120.001.120.00.00.0 Ultrafiltration, L0.10.10.10.10.10.10.1 Distribution volume, L36.036.036.036.036.036.036.0 Generation rate, µmol/min200200200200200200200Output parameters nPCR, g/kg/day1.011.011.011.011.011.011.01 PAC, mmol/L26.319.323.417.117.219.321.9 TAC~c~, mmol/L17.513.217.713.48.910.813.2 TAC~d~, mmol/L14.010.35.57.59.9 TAC~i~, mmol/L17.813.49.611.313.6 Average removal rate by kidneys, µmol/min0.052.90.00.00.0 Average removal rate by dialysis, µmol/min199.9147.1200.0200.0200.0 Average total removal rate (sum), µmol/min199.9200.0200.0200.0200.0 Renal contribution to urea removal, %0.026.50.00.00.0 EKR, mL/min11.415.111.315.022.518.515.1 EKR/*V*, per week3.21**4.25**3.164.196.325.20**4.25** EKR/*V*~d~, per week3.203.126.315.184.23 EKR/*V*~r~, per week0.001.120.000.000.00 EKR/*V*~t~ (sum), per week3.204.246.315.184.23 Renal contribution to EKR/*V*, %0.026.50.00.00.0 stdK, mL/min7.610.37.611.611.610.39.1 stdK/*V*, per week2.12**2.89**2.13**3.253.252.89**2.55 stdK/*V*~d~, per week2.122.132.132.133.252.892.55 stdK/*V*~r~, per week0.000.770.000.000.00 stdK/*V*~t~ (sum), per week2.122.903.252.892.55 Renal contribution to stdK/*V*, %0.026.50.00.00.0[^1]Table 2.An example of adjusting EKR/*V* with a K~r~ adjusting coefficient of 2.0With nominal K~r~With adjusted K~r~Input parameters Treatment frequency, per week3.03.0**3.02.0** Treatment time, min240240**145237** Dialyser clearance, mL/min200200200200 Renal clearance, mL/min0.0**4.04.04.0** Renal fractional clearance, per week0.001.121.121.12 Ultrafiltration, L0.10.10.10.1 Distribution volume, L36.036.036.036.0 Generation rate, µmol/min200200200200 K~r~ adjusting coefficient**1.01.02.02.0**Output parameters nPCR, g/kg/day1.011.011.011.01 PAC, mmol/L26.319.323.325.8 TAC~c~, mmol/L17.513.217.917.9 TAC~d~, mmol/L14.010.314.913.7 TAC~i~, mmol/L17.813.418.118.1 Average removal rate by kidneys, µmol/min0.052.971.671.5 Average removal rate by dialysis, µmol/min199.9147.1128.3128.4 Average total removal rate (sum), µmol/min199.9200.0199.9199.9 Renal contribution to urea removal, %0.026.535.835.8 EKR, mL/min11.415.111.211.2 EKR/*V*, per week3.21**4.25**3.143.14 EKR/*V*~d~, per week3.203.122.012.01 EKR/*V*~r~, per week0.001.121.121.12 EKR/*V*~t~ (sum), per week3.204.243.133.13 Renal contribution to EKR/*V*, %0.026.435.835.8 Adjusted EKR/*V*, per week3.205.36**4.254.25** stdK/*V*, per week2.122.892.402.17 stdK/*V*~d~, per week2.122.131.541.39 stdK/*V*~r~, per week0.000.770.860.78 stdK/*V*~t~ (sum), per week2.122.902.402.17 Renal contribution to stdK/*V*, %0.026.535.835.9 Daugirdas's stdK/*V*, per week2.123.252.662.51[^2]

A total of 200 new prescriptions, fulfilling a set of limits and targets, were generated automatically with an optimizing program. G and V were computed from the actual modelling sessions with a double-pool UKM program adapted from the Solute Solver, with three plasma urea samples, interdialysis urine collection and K~d~ from ionic dialysance. Q~b~, Q~d~ and t~d~ were computed by numeric solution of the UKM equations. The program begins with minimum fr, t~d~, Q~b~ and Q~d~, preferentially increases Q~b~ and t~d~ and only increases the frequency as a last option.

In this material, the stdK/*V* target of 2.30/week corresponded to an average EKR/*V* value of 3.23/week and the EKR/*V* target of 3.20/week to an average stdK/*V* value of 2.21/week. A stdK/*V* value of 2.20/week and an EKR/*V* value of 3.20/week were chosen as optimization targets in the present study. All limits and targets used in generating the optimized prescriptions are listed in [Table 3](#sfy036-T3){ref-type="table"}. In this study, clearances are water values, in the earlier work plasma values \[[@sfy036-B11]\]. Table 3.Limits and targets for optimized prescriptionsMinimumMaximumfr, per week17t~d~, min240300Q~b~, mL/min50300Q~d~, mL/min300800K~0~A, mL/min800800stdK/*V*, per week2.20EKR/*V*, per week3.20PAC, mmol/L 30.0TAC, mmol/L20.0[^3]

For incremental dialysis, the K~r~ adjusting coefficient (AC) and adjusted total EKR/*V* (EKR/*V*~a~) are defined. If the RRF is believed to be qualitatively better than dialysis with equal urea clearance, a value \>1 is given to the coefficient. Casino and Basile suggested a new EKR/*V* target ([Equation 25](#E25){ref-type="disp-formula"}) and a new variable Adjusted EKR/V ([Equation 26](#E26){ref-type="disp-formula"}): $$\text{New~EKR}/V\text{~target~} = \text{~minimum~EKR}/V\ –\ {({\text{AC~}–\ 1})}*K_{\text{rf}}$$$$\text{Adjusted~EKR}/V = \text{~modelled~EKR}/V\  + \ {({\text{AC~}–\ 1})}*\, K_{\text{rf}}$$

It turned out that [Equation (24)](#E24){ref-type="disp-formula"} resulted in values equal to those obtained with the combination of [Equations (25)](#E25){ref-type="disp-formula"} and [(26](#E26){ref-type="disp-formula"}), which may be obvious also from [Equation (10)](#E10){ref-type="disp-formula"}. [Equation (24)](#E24){ref-type="disp-formula"} is easier to understand than the original Casino and Basile target-adjusting method and analogous to Daugirdas's stdKt/*V* from [Equation (19)](#E19){ref-type="disp-formula"}. EKR/*V*~d~ was calculated according to [Equations (11)](#E11){ref-type="disp-formula"}, [(20)](#E20){ref-type="disp-formula"} and [(21)](#E21){ref-type="disp-formula"}. EKR/*V*~a~ is compared to the EKR/*V* target and is a therapeutic index, not a formally correct urea clearance measure.

The HDOptimizer demonstration program (<http://www.verkkomunuainen.net/optimize.html>) automatically generates haemodialysis prescriptions that fulfil 12 limits and targets. It is not intended to be used to treat patients, only to demonstrate the principles.

RESULTS
=======

Actual dialysis sessions
------------------------

Table [4](#sfy036-T4){ref-type="table"} describes the actual dialysis sessions with substantial RRF and demonstrates the effects of K~r~ adjusting and the Daugirdas\' method on the ECC values. Table 4.Average values of actual dialysis sessions where K~r~ is \>1.0 mL/minPatients16Sessions62Mean (SD)Renal urea clearance, mL/min2.2 (0.9)Urea distribution volume, L34.9 (6.6)Urea generation rate, µmol/min202 (69)Treatment frequency, per week2.94 (0.27)Treatment time, min300 (62)Total dialyser clearance, mL/min205 (15)Ultrafiltration, L2.6 (1.2)Classic EKR/*V*, per week4.59 (0.66)Adjusted EKR/*V*[^a^](#tblfn4){ref-type="table-fn"}, per week5.23 (0.70) Difference, %14.4 (5.7)Classic stdK/*V*, per week2.97 (0.33)Daugirdas's stdK/*V*, per week3.19 (0.36) Difference, %7.5 (2.5)[^4]

Daugirdas's stdK/*V*
--------------------

The example in [Table 1](#sfy036-T1){ref-type="table"} clarifies the calculations. The input parameters are arbitrary, except the renal fractional clearance K~rf~ calculated from the renal clearance K~r~ and the distribution volume V \[[Equation (14)](#E14){ref-type="disp-formula"}\].

The total urea removal rate calculated from the input values of K~d~ and K~r~ equals the modelled generation rate G. In the 'Without RRF' columns are presented the treatment times required to achieve ECC values equal to those with RRF. With the conventional three times per week schedule without RRF, ECC values are within the guidelines' lower limits but are increased by RRF to a level difficult to achieve without RRF.

In [Table 1](#sfy036-T1){ref-type="table"} (with quite high K~r~), Daugirdas's stdKt/*V* with RRF (in the second 'Daugirdas' column) is 12.5% higher than the modelled classic one (3.25 versus 2.89). The difference between the classic and Daugirdas's stdK/*V* is observed only in sessions with RRF.

Adjusted EKR/*V*
----------------

[Table 2](#sfy036-T2){ref-type="table"} shows an example of EKR/*V* calculations with AC of 2.0. The EKR/*V*~a~ target can be achieved with two sessions per week. TAC, PAC and renal contribution are higher than without K~r~ adjusting.

The AC has no effect if its value is 1 or if K~r~ = 0. It affects only EKR/*V*~a~, not Daugirdas's stdK/*V*. In incremental dialysis, EKR/*V*~a~ can be used as the main target to produce schedules resembling those used by Casino and Basile; stdK/*V* can be disregarded by setting a low minimum total stdK/*V* in the program. Emphasizing the clinical value of RRF by using an AC \>1 inevitably increases urea concentrations ([Table 5](#sfy036-T5){ref-type="table"}). The correct value of the AC is not known. It could, of course, be used also in modifying Daugirdas's stdK/*V*. Table 5.Average values of optimized prescriptions with four different targets in 62 sessions where K~r~ is \>1 mL/min (mean 2.2 mL/min, mean fractional clearance 0.64/week)TargetClassic EKR/V, 3.20/weekAdjusted[^a^](#tblfn5){ref-type="table-fn"} EKR/V, 3.20/weekClassic stdK/V, 2.20/weekDaugirdas's stdK/V, 2.20/weekDialysis EKR/*V*, per week2.561.922.472.15Classic EKR/*V*, per week**3.20**2.563.112.79Adjusted EKR/*V*[^a^](#tblfn5){ref-type="table-fn"}, per week3.84**3.20**3.753.43Dialysis stdK/*V*, per week1.781.411.741.56Classic stdK/*V*, per week2.221.89**2.20**2.03Daugirdas's stdK/*V*, per week2.422.052.38**2.20**TAC, mmol/L16.721.017.219.2PAC, mmol/L24.028.424.226.3Treatment time, h/week9.78.510.19.3Treatment frequency, per week2.32.12.42.3[^5]

The competition between the kidneys and dialysis for blood urea can be seen in [Table 2](#sfy036-T2){ref-type="table"}; urea removal by the kidneys increases when the dialysis time or frequency decrease. With adjusted K~r~, the concentrations are considerably higher, close to those without RRF, and unadjusted total EKR/*V* is lower.

Comparison of the methods
-------------------------

In Daugirdas's stdK/*V*, 100% of K~rf~ is added to the modelled (compressed) dialysis stdK/*V* \[[Equation (19)](#E19){ref-type="disp-formula"}\], whereas in the Casino and Basile method, the weighted K~rf~ is added to the modelled dialysis EKR/*V* \[[Equation (24)](#E24){ref-type="disp-formula"}\]. In the original Casino and Basile approach, the therapeutic value of renal function is assumed to be exactly 2-fold compared to haemodialysis with equal urea clearance. [Figure 1](#sfy036-F1){ref-type="fig"} shows the correlation between the results by the two methods.

![Correlation of Daugirdas's modified total stdKt/*V* and adjusted (with K~r~ adjusting coefficient of 2.0) total EKR/*V* in 89 actual haemodialysis sessions with RRF.](sfy036f1){#sfy036-F1}

In actual sessions with K~r~ \>1 mL/min, using an AC of 2.0 resulted in 14.4% higher EKR/*V* than without adjusting and 7.5% higher stdKt/*V* with the Daugirdas method compared with the classic stdK/*V* ([Table 4](#sfy036-T4){ref-type="table"}). The patients were seemingly 'overdialysed' according to the current guidelines.

[Tables 5](#sfy036-T5){ref-type="table"} and [6](#sfy036-T6){ref-type="table"} present data from optimized prescriptions. Optimizing with unadjusted EKR/*V* of 3.20/week as the only target in incremental dialysis results in higher clearances and lower concentrations, with lower resource consumption (time and frequency), than using classic stdK/*V* of 2.20/week ([Table 5](#sfy036-T5){ref-type="table"}). With adjusted EKR/*V* as the only target, all values show a lower dialysis dose and higher weight given to RRF, compared with Daugirdas's stdKt/*V*. Table 6.Treatment frequency distribution of 200 optimized prescriptions with four different targetsFrequency, /weekClassic EKR/V, 3.20/weekAdjusted[^a^](#tblfn6){ref-type="table-fn"} EKR/V, 3.20/weekClassic stdKt/V, 2.20/weekDaugirdas's stdKt/V, 2.20/week1.0612.0697342523.01301201571463.51111[^6]

[Tables 5](#sfy036-T5){ref-type="table"} and [6](#sfy036-T6){ref-type="table"} show that optimizing with an adjusted EKR/*V* target of 3.20/week allows lower weekly treatment times and frequencies than Daugirdas's stdKt/*V* of 2.20. Casino and Basile have applied successfully once-per-week incremental dialysis. Their method with a K~r~ adjusting coefficient of 2.0 used in this study gives more weight to RRF and results in lower consumption of dialysis resources compared with the Daugirdas stdKt/*V* method.

[Figure 2](#sfy036-F2){ref-type="fig"}, based on [Equations (11)](#E11){ref-type="disp-formula"} and [(12)](#E12){ref-type="disp-formula"}, shows that the renal contribution to total urea removal can be \>50% when an adjusted EKR/*V* of 3.20/week is used as the target in incremental dialysis. A Daugirdas stdK/*V* of 2.20/week gives slightly less value to RRF.

![Renal contribution to total urea removal in 89 actual and simulated haemodialysis sessions with RRF. Adjusted EKR/*V* and Daugirdas's stdK/*V* values are from optimized prescriptions, with the corresponding parameter as the only target (3.20/week and 2.20/week, respectively). ^1^With K~r~ adjusting coefficient 2.0.](sfy036f2){#sfy036-F2}

These results are based on computer simulations, not on empirical measurements from patients. In the simulations, the 'patients' are 'dialysed' optimally with an *in vivo* K~0~A of 800 mL/min to exact targets.

DISCUSSION
==========

The equation stdK = *G*/PAC \[[@sfy036-B5], [@sfy036-B12], [@sfy036-B13]\] is a conventional clearance equation and its units may be, for example, mL/s, mL/min, L/h or L/wk. When G/PAC is divided by *V*, we get *G*/PAC/*V* = stdK/*V* \[[Equation (1)](#E1){ref-type="disp-formula"}\]. Where does 't' come from? The most convenient unit of stdK/*V* and EKR/*V* is per week. There exist in the literature several variations of the term 'stdKt/*V*'. Sometimes stdKt/V has been confused with session Kt/*V* or weekly Kt/*V*, as in the abstract of reference \[[@sfy036-B8]\]. EKR/*V* or EKRt/*V* have not been widely used in the literature, therefore we have an opportunity to select the correct term and unit. For comparison with EKR/*V*, the other variable should have the same format. Here, stdK/*V* and stdKt/*V* are used as synonyms.

The differences in concentrations between the 'Classic' and 'Daugirdas' columns in [Table 1](#sfy036-T1){ref-type="table"} are due mainly to differences between the 'frequency' and 'schedule' input modes. The small differences in the third or fourth number of corresponding values are caused by inaccuracy of the multiple sequential iterations in their computation.

In pursuing a universal equivalent continuous clearance, PAC was used as the denominator in stdKt/*V*, instead of the formally more correct TAC~c~, to get values close to those in continuous ambulatory peritoneal dialysis (CAPD) \[[@sfy036-B6], [@sfy036-B12], [@sfy036-B14]\]. stdK/*V* is related to the peak concentration hypothesis \[[@sfy036-B15]\]. In the classic stdK/*V*, compression of K~r~ (as well as K~d~) is due mainly to the 'wrong' denominator, but the calculation method---subtracting ECC values computed with K~r~ = 0 from corresponding total values---causes 'compression' of K~r~ also in EKR/*V*. In this article and in the HDOptimizer program, the dialysis contribution to stdK/*V* and EKR/*V* is calculated by [Equations (11)](#E11){ref-type="disp-formula"}, [(16)](#E16){ref-type="disp-formula"}, [(20)](#E20){ref-type="disp-formula"} and [(21)](#E21){ref-type="disp-formula"}. EKR is usually lower in CAPD than in intermittent haemodialysis.

The original Gotch \[[@sfy036-B13]\] and Leypoldt \[[@sfy036-B16], [@sfy036-B17]\] equations do not include RRF. The idea of adding uncompressed K~rf~ to compressed stdK/*V*~d~ to emphasize the clinical significance of RRF is formally questionable.

*G*/PAC/*V* (stdK/*V*) and *G*/TAC~c~/*V* (EKR/*V*) are different descriptors of dialysis dosing, each with its own individual characteristics, value ranges and targets \[[@sfy036-B18]\]. stdK/*V* is more sensitive to RRF \[[@sfy036-B19]\] and treatment frequency \[[@sfy036-B20]\] than EKR/*V*, but less sensitive to poor spacing (asymmetry of the schedule) \[[@sfy036-B21]\]. In the example in [Table 1](#sfy036-T1){ref-type="table"}, without RRF, 372 min (6.2 h; 155%) longer treatment time is required to achieve equal stdK/*V* as with RRF when using the Daugirdas calculation and 212 min (3.5 h; 88%) longer with classic stdK/*V*, but only 100 min (1.7 h; 42%) longer to control EKR/*V*. The essential questions are how to weight RRF and which of the following is more important in terms of outcome---PAC or TAC, peak or average concentration. It was recently shown in a small population that survival correlated significantly with EKR/*V* but not with stdK/*V* \[[@sfy036-B22]\].

The KDOQI 2015 guidelines recommend the Daugirdas method to adjust stdKt/*V* upwards, but it is unclear by which method the target (2.3) has been determined. In the presence of RRF, stdKt/*V* values computed with the Daugirdas modification are not comparable to those from early versions of the Solute Solver. To avoid confusion, the new '100%' variable must not be called stdKt/*V*; it is a new index used in the FHN trials \[[@sfy036-B8], [@sfy036-B9]\], but probably with no impact on their results.

EKR/*V*~a~ is an index where the renal urea clearance can be weighted flexibly by the AC; the EKR/*V* target is held unchanged and is compared to EKR/*V*~a~. In the Daugirdas method, K~rf~ is added to the modelled dialysis stdK/*V*~d~ \[Equation (19)\], whereas in the K~r~ adjusting method, K~rf~ is replaced in EKR/V~a~ by the adjusted K~rf~ \[Equation [(24)](#E24){ref-type="disp-formula"}\].

The stdK/*V* concept is distorted due to an attempt to combine CAPD, the peak concentration hypothesis and haemodialysis urea kinetics by using a wrong denominator. Differences between outcomes in CAPD and intermittent haemodialysis can be explained by factors other than urea clearance, for example, patient selection, intermittency of haemodialysis and differences in membrane permeability to uraemic toxins. The measuring method should not be modified with a view to obtaining the desired results.

In intermittent haemodialysis, treatment time and frequency, convection, fluid removal and RRF all affect the outcome, in addition to urea clearance. Haemodialysis dosing cannot be described by only one number. In the FHN trial \[[@sfy036-B8]\], dialyser clearance was equal in both groups, but weekly treatment time and stdKt/*V* were significantly higher in the frequent haemodialysis group. Therefore it remains obscure whether the better outcome was due to higher frequency or longer weekly treatment time or higher urea clearance.

stdK/*V* and its modifications are calculated therapeutic or prognostic indexes, not measures of urea clearance. It is more appropriate to include K~r~ as clinically undervalued---but uncompressed in EKR/*V*---than to totally disregard it. If the goal is to reduce dialysis, adjusted EKR/*V* is more suitable for that purpose than Daugirdas's stdK/*V*. It will be harder to meet the Daugirdas stdKt/*V* target of 2.20/week than the adjusted EKR/*V* target of 3.20/week with once- or twice-weekly incremental dialysis. There are no empirical data to show how RRF should be weighted or what the effects of reducing the treatment intensity on outcomes in incremental dialysis are.

CONCLUSIONS
===========

The relationships EKR/*V* = G/TAC/*V* and stdK/*V* = *G*/PAC/*V* hold, even in the presence of RRF, if K~r~ is appropriately included in the calculation of G and V. EKR/*V* is a formally correct physical measure of total urea clearance---one component of haemodialysis dosing---and not a prognostic index. The significance of RRF may be handled by adjusting the weight of renal clearance without changing the EKR/*V* target.
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Appendix
========

Abbreviations and variablesHDhaemodialysisCAPDcontinuous ambulatory peritoneal dialysisKDOQIKidney Disease Outcomes Quality InitiativeECCequivalent continuous clearanceUKMurea kinetic modelVtotal postdialysis urea distribution volume (L)Gurea generation rate (µmol/min)frtreatment frequency (sessions per week)t~d~dialysis session duration (min)t~i~interval time between sessions (min)Q~b~blood flow (mL/min)Q~d~dialysate flow (mL/min)K~d~total dialyser urea clearance (mL/min)K~r~renal urea clearance (mL/min)K~rc35~renal urea clearance normalized to 35 L body water (mL/min/35 L)K~rf~renal fractional urea clearance (/wk)E~d~average urea removal rate by dialysis (µmol/min)E~r~average urea removal rate by the kidneys (µmol/min)E~t~average total urea removal rate (µmol/min)TAC~d~time-averaged plasma water urea concentration during dialysis (mmol/L)TAC~i~time-averaged plasma water urea concentration during the interval (mmol/L)TAC~c~time-averaged plasma water urea concentration of the whole dialysis cycle (mmol/L)PACaverage predialysis plasma water urea concentration (mmol/L)stdKstandard urea clearance (mL/min)stdK/V~t~total stdK/V (/wk)stdK/V~d~dialysis contribution to stdK/V~t~ (/wk)stdK/Vrrenal contribution to stdK/Vt (/wk)stdKt/V~Dau~Daugirdas' total stdKt/VEKRequivalent renal urea clearance (mL/min)EKR~c~normalized EKR (mL/min/35 L or mL/min/40 L)EKR~d~dialysis EKR (mL/min)EKR~c35~EKR normalized to 35 L urea distribution volume (mL/min/35 L)EKR~dc35~dialysis EKRc35 (mL/min/35 L)EKR/V~t~total EKR/V (/wk)EKR/V~d~dialysis contribution to EKR/V~t~ (/wk)EKR/V~r~renal contribution to EKR/V~t~ (/wk)EKR/V~a~adjusted total EKR/V (/wk)K~0~Adialyser mass-area coefficient (mL/min)ACK~r~ Adjusting Coefficient
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One week is 10080 minutes. TAC~d~ and TAC~i~ are derived from the double-pool concentration profile. In metabolic equilibrium, the average generation rate G = E~t~.

[^1]: Mon-Wed-Fri schedule with blood samples drawn on Wednesday. Compare especially the bold numbers.

[^2]: Compare especially the bold numbers.

[^3]: In the optimization program, all limits and targets, except minimum blood flow, can be set freely.

[^4]: With K~r~ adjusting coefficient of 2.0.

[^5]: With K~r~ adjustment coefficient of 2.0. Treatment time 240--300 min, blood flow 50--300 mL/min, dialysate flow 300--800 mL/min, dialyser *in vivo* K~0~A 800 mL/min. In each target column, the other targets have been disregarded. Compare especially the bold values.

[^6]: With K~r~ adjustment coefficient 2.0. Treatment time 240--300 min, blood flow 50--300 mL/min, dialysate flow 300--800 mL/min, dialyser *in vivo* K~0~A 800 mL/min. In each target column, the other targets have been disregarded.
